tiprankstipranks
Trending News
More News >
Solasia Pharma KK (JP:4597)
:4597
Japanese Market

Solasia Pharma KK (4597) Income Statement

Compare
1 Followers

Solasia Pharma KK Income Statement

Last quarter (Q3 2025), Solasia Pharma KK's total revenue was ¥42.00M, an increase of 366.67% from the same quarter last year. In Q3, Solasia Pharma KK's net income was ¥-171.00M. See Solasia Pharma KK’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 316.00M¥ 617.00M¥ 1.09B¥ 559.00M¥ 454.00M
Gross Profit
¥ 185.00M¥ 337.00M¥ 662.00M¥ 374.00M¥ 245.00M
Operating Expenses
¥ 2.14B¥ 1.48B¥ 3.13B¥ 2.79B¥ 4.36B
Depreciation and Amortization
¥ 195.00M¥ 500.00M¥ 534.00M¥ 495.00M¥ 496.00M
EBITDA
¥ -1.75B¥ -635.00M¥ -1.94B¥ -1.92B¥ -3.62B
Operating Income
¥ -991.00M¥ -1.14B¥ -2.47B¥ -2.42B¥ -3.31B
Other Income/Expenses
¥ -970.00M¥ 4.00M¥ -21.00M¥ -23.00M¥ -844.00M
Pretax Income
¥ -1.96B¥ -1.14B¥ -2.49B¥ -2.44B¥ -4.16B
Net Income
¥ -1.94B¥ -1.11B¥ -2.55B¥ -2.48B¥ -4.13B
Per Share Metrics
Basic EPS
¥ -9.77¥ -6.61¥ -16.76¥ -19.03¥ -35.16
Diluted EPS
¥ -9.77¥ -6.61¥ -16.76¥ -19.03¥ -35.16
Weighted Average Shares Outstanding
198.67M 168.13M 151.99M 130.15M 117.38M
Weighted Average Shares Outstanding (Diluted)
198.70M 168.13M 151.99M 130.15M 117.38M
Currency in JPY

Solasia Pharma KK Earnings and Revenue History